Cancer Genetics & Molecular Oncology
Clinician referral requiredABL1 Kinase Domain Mutations (TKI Resistance)
Looks for ABL1 mutations linked to resistance to tyrosine kinase inhibitor treatment in BCR-ABL positive leukaemia.
Test code:
Sample
Blood
Method
Next Generation Sequencing (NGS)
Turnaround
21 days
About this test
Looks for ABL1 mutations linked to resistance to tyrosine kinase inhibitor treatment in BCR-ABL positive leukaemia.
Screens forChronic myeloid leukaemia
Yes, a doctor's referral is required for this test.
No special preparation is usually required; confirm specimen-specific instructions with the laboratory.
Samples can be collected at the GeneLabs X Centre in Kotte or at any of our designated sample collection centres.
The results indicate whether mutations are detected in the ABL tyrosine kinase (TK) domain. Discuss the results with your doctor before making any decisions.
Need help?
Not sure this is the right test?
Our team can help you or your clinician find the right pathway.
